HR-VWI影像组学预测症状性ICAS一年不良事件:斑块-血管整合模型与单纯斑块模型比较
本研究回顾性纳入272例症状性颅内动脉粥样硬化性狭窄(ICAS)患者,按时间划分训练/验证队列(2022年,133例)和独立时间测试队列(2023年,139例)。从T1加权和对比增强T1加权HR-VWI中提取影像组学特征,构建单纯斑块模型和斑块-血管整合模型,主要终点为1年不良临床事件复合结局。
要点
- 斑块-血管整合影像组学模型预测1年不良事件AUC达0.800,优于常规临床评分系统
- 决策曲线分析显示整合模型在多数阈值概率下净获益高于单纯斑块模型和临床评分
核心结论
- 斑块-血管整合影像组学模型预测症状性ICAS患者1年不良事件显著优于常规临床评分和常规视觉斑块评估
- 整合模型与单纯斑块模型之间统计学差异不明确,研究结果仍属探索性
- 模型在大规模验证前尚不能用于指导常规临床决策
研究设计与样本
- 回顾性研究,纳入272例症状性颅内动脉粥样硬化性狭窄(ICAS)患者
- 按时间划分:2022年患者133例构成训练和验证队列,2023年患者139例作为独立时间测试队列
- 影像组学特征提取自T1加权和对比增强T1加权HR-VWI序列
- 构建两种影像组学标签:单纯斑块模型(仅斑块ROI)和斑块-血管整合模型(纳入斑块、血管壁和管腔)
- 主要终点为1年不良临床事件复合终点,采用AUC和决策曲线分析评估性能
关键影像表现/征象
- 对比增强T1加权HR-VWI上可见斑块强化
- HR-VWI上可见斑块内出血表现
- HR-VWI上可见正性重构征象
诊断标准与关键数值
- 斑块-血管整合模型时间测试集AUC为0.800(95%CI:0.724-0.863)
临床应用与阅片要点
- 斑块-血管整合影像组学特征包含斑块、血管壁和管腔信息,预测效能优于单纯斑块ROI特征
- 定性影像模型纳入的斑块内出血、斑块强化和正性重构等征象单独预测价值有限,需结合影像组学量化分析
- 校准曲线显示整合模型预测概率与实际结局一致性良好
- 决策曲线分析显示整合模型在多数阈值概率下净临床获益最高
局限性
- 回顾性单中心设计,时间测试集数据来自同一机构
- 需要更大规模前瞻性验证后方可评估临床适用性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To compare an integrated "Plaque-Vessel" high-resolution vessel wall imaging (HR-VWI) radiomics model against a "Plaque-only" model for predicting 1-year adverse clinical events in symptomatic intracranial atherosclerotic stenosis (ICAS).
MATERIALS AND METHODS: This retrospective study enrolled 272 symptomatic ICAS patients. A temporal split was applied: patients from 2022 (n = 133) constituted the training and validation cohorts, while those from 2023 (n = 139) served as an independent temporal test cohort. Radiomic features were extracted from T1-weighted and contrast-enhanced T1-weighted HR-VWI. Two signatures were constructed: a "Plaque" model (plaque ROI only) and a "Plaque-Vessel" model (incorporating plaque, vessel wall, and lumen). The primary endpoint was a composite of 1-year adverse clinical events. Performance was assessed using the area under the curve (AUC) and decision curve analysis (DCA), comparing against a qualitative imaging model (comprising intraplaque hemorrhage, plaque enhancement, and positive remodeling), the Essen Stroke Risk Score (ESRS), and NIHSS.
RESULTS: The Plaque-Vessel model yielded the highest predictive performance, achieving an AUC of 0.800 (95% CI: 0.724-0.863) in the temporal test set. This performance showed a trend toward improvement compared to the Plaque-only model (AUC = 0.721, P = .27) and significantly outperformed the qualitative plaque features model (AUC = 0.631, P = .03), ESRS (AUC = 0.554, P < .01), and NIHSS (AUC = 0.543, P < .01). Calibration curves showed good agreement. DCA demonstrated that the Plaque-Vessel signature provided greater net clinical benefit than the Plaque-only model or clinical scores across the majority of threshold probabilities.
CONCLUSION: The integrated Plaque-Vessel radiomics model significantly outperforms conventional clinical scores and routine visual plaque assessment for predicting 1-year adverse events. However, given the inconclusive statistical difference between the integrated and plaque-only models, these findings remain exploratory. The model requires further large-scale validation before it can be considered ready to guide routine clinical decisions.
引用
- Gao, Lu, Fan, et al. HR-VWI Radiomics for Predicting 1-Year Adverse Events in Symptomatic ICAS: A Comparison of Plaque-Only and Integrated Plaque-Vessel Models. Acad Radiol. 2026. PMID: 42570909. doi:10.1016/j.acra.2026.07.049
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。